| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e88b5bdcc77f65ae734ebaacffeef1ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_859131a3691229508ca9d60cc5f8d683 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 |
| filingDate |
2015-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70a6c76ea61a92ba6e549816cbd89ab4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_caa36ef40a2e3f1d728bef6e8e4947b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_067492490f5612a5a1810a42cfe37749
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9e20259666be8e78537e2d8b1b3ee27 |
| publicationDate |
2017-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-107205988-A |
| titleOfInvention |
Treatment of leukemia with histone deacetylase inhibitors |
| abstract |
Provided herein are combinations comprising an HDAC inhibitor and azacitidine for use in the treatment of leukemia in a subject in need thereof. Also provided herein is a combination comprising an HDAC inhibitor and azacitidine for the treatment of acute myelogenous leukemia in a subject in need thereof. Also provided herein are methods for treating leukemia in a subject in need thereof, comprising administering to the subject an effective amount of the above combination or an HDAC inhibitor, and for treating acute myeloid leukemia in a subject in need thereof. A method of leukemia comprising administering to a subject an effective amount of the above combination or an HDAC inhibitor. |
| priorityDate |
2014-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |